Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
1.50
Oct 26 • 3:59 PM ET Dollar change0.00 Percentage change(0.00%)
Index
-
Market Cap
48.28M
Enterprise Value
50.56M
Income
-10.50M
Sales
15.16M
Book/sh
-0.37
Cash/sh
0.43
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
65
IPO
Apr 06, 2021
P/E
-
Forward P/E
-
PEG
-
P/S
3.18
P/B
-
P/C
3.45
P/FCF
-
EV/EBITDA
-
EV/Sales
3.34
Quick Ratio
0.85
Current Ratio
0.90
Debt/Eq
-
LT Debt/Eq
-
Option/Short
No / Yes
EPS (ttm)
-0.35
EPS next Y
-0.31
EPS next Q
-0.14
EPS this Y
-60.92%
EPS next Y
33.57%
EPS next 5Y
-0.00%
EPS past 3/5Y
-8.80% -
Sales past 3/5Y
-8.16% -
EPS Y/Y TTM
48.57%
Sales Y/Y TTM
-44.99%
EPS Q/Q
58.46%
Sales Q/Q
-30.42%
Insider Own
16.24%
Insider Trans
0.00%
Inst Own
12.06%
Inst Trans
9.45%
ROA
-59.24%
ROE
-
ROIC
-
Gross Margin
41.51%
Oper. Margin
-79.95%
Profit Margin
-69.27%
SMA20
-4.94%
SMA50
-5.76%
SMA200
-11.97%
Trades
Shs Outstand
32.18M
Shs Float
26.96M
52W High
2.97 -49.49%
52W Low
1.18 27.12%
Volatility
3.43% 3.93%
ATR (14)
0.06
RSI (14)
40.57
Beta
1.24
Rel Volume
0.00
Avg Volume
141.24K
Volume
0
Perf Week
-1.32%
Perf Month
-5.66%
Perf Quarter
-3.85%
Perf Half Y
-23.47%
Perf YTD
5.63%
Perf Year
-32.43%
Perf 3Y
-39.02%
Perf 5Y
-84.66%
Perf 10Y
-
Prev Close
1.50
Price
1.50
Change %
0.00%
Date Action Analyst Rating Change Price Target Change
Jan-23-24Initiated BTIG Research Buy $4
Spectral AI, Inc. is a predictive artificial intelligence company. It focuses on medical diagnostics for accurate treatment decisions in wound care for burn, DFU, and future clinical applications. Its DeepView platform is a predictive diagnostic device that offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention. The company was founded by John Michael DiMaio and Wen Sheng Fan on November 17, 2020 and is headquartered in Dallas, TX.
Founder & ChairmanDr. John Michael DiMaio M.D.
CEO & Corporate SecretaryMr. Vincent Stanley Capone Esq.
Chief Operating OfficerMr. Stanley Micek
Head of Regulatory Affairs & Clinical TrialsMs. Allison Kumar
General ManagerMr. Louis Percoco